Corporate Bond Fund – Featured
January 11, 2022
The Latest
Corporate Bond Fund – August 2024
Highlights Key performance contributors included convertible bonds in Revance Therapeutics Inc., OPKO Health Inc., and Cineplex Inc. Key detractor was Stem Inc. We added weight to several lines of existing credits including Crowdstrike Holdings Inc, which we consider an extremely strong credit, and to our existing holdings of Canadian real return bonds. Download the pdf The Pender Corporate Bond Fund returned 0.9% in August[1]. This good result was achieved within the context of a generally favorable credit market that shrugged off volatility caused by the unwinding of some yen carry trades early in the month. Key contributors for the period…
